{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:20:12Z","timestamp":1761513612727},"reference-count":190,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.autrev.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T03:42:28Z","timestamp":1428291748000},"page":"622-632","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The 2014 ACR annual meeting: a bird\u2019s eye view of autoimmunity in 2015"],"prefix":"10.1016","volume":"14","author":[{"given":"Carlo","family":"Selmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaye","family":"Kivity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Dagaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ora","family":"Shovman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisele","family":"Zandman-Goddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Toubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2015.03.003_bb0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.autrev.2014.12.001","article-title":"Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis","volume":"14","author":"Chora","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sjogren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.autrev.2013.11.001","article-title":"Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection","volume":"13","author":"Terrier","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.autrev.2014.11.004","article-title":"Systematic review: New serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes","volume":"14","author":"Bonneau","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2012.09.001","article-title":"Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy","volume":"12","author":"Maiti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.11.009","article-title":"Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease","volume":"57","author":"Roberts","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.autrev.2014.08.020","article-title":"The efficacy of novel B cell biologics as the future of SLE treatment: a review","volume":"13","author":"Kamal","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0045","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.autrev.2012.11.011","article-title":"The impact of the profile of biologics on treatment costs","volume":"12","author":"Leardini","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2012.08.013","article-title":"Can we reduce the dosage of biologics in spondyloarthritis?","volume":"12","author":"Olivieri","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.autrev.2014.08.038","article-title":"Identification of a novel myositis-associated antibody directed against cortactin","volume":"13","author":"Labrador-Horrillo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies-anti-TIF1gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48\u201349","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0070","first-page":"S551","article-title":"A New multianalyte assay for detection of dermatomyositis-specific autoantibodies undetectable by commercially available immunoassays","volume":"66","author":"Kuwana","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0075","first-page":"S554","article-title":"Anti-MDA5 is associated with rapidly-progressive interstitial lung disease and poor survival in U.S. Patients with amyopathic and myopathic dermatomyositis","volume":"66","author":"Moghadam-Kia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2013.11.007","article-title":"Patterns of systemic lupus erythematosus expression in Europe","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48\u201349","author":"Kuhn","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0095","first-page":"S708","article-title":"IFN-\u2019 (Th1), IL4 (Th2), and IL5 (Th2) Are elevated in Pre-clinical SLE and predict transition to classified disease prior to appearance of autoantibodies or clinical criteria","volume":"66","author":"Lu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0100","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2010.08.001","article-title":"Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis","volume":"49","author":"Duryee","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.autrev.2015.03.003_bb0105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.38969","article-title":"Malondialdehyde-acetaldehyde adducts (MAA) and anti-MAA antibody in rheumatoid arthritis","volume":"67","author":"Thiele","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0110","first-page":"S715","article-title":"Antibody to malondialdehyde-acetaldehyde adducts (MAA) as a Po- tential biomarker of inflammation in systemic lupus erythrematosus (SLE)","volume":"66","author":"Hollins","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0115","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.autrev.2014.08.033","article-title":"Good prognosis for hospitalized SLE patients with non-related disease","volume":"13","author":"Zimlichman","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: not a passive bystander","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0125","first-page":"S573","article-title":"Does anti-C1q antibody have diagnostic and prognostic roles in childhood \u2013 onset systemic lupus erythematosus?","volume":"66","author":"Arka- chaisri","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2014.01.030","article-title":"CD4(\u2212)CD8(\u2212) T-cells in primary Sjogren's syndrome: association with the extent of glandular involvement","volume":"51","author":"Alunno","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.02.001","article-title":"Sjogren's syndrome and the epithelial target: a comprehensive review","volume":"42","author":"Barrera","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2014.02.002","article-title":"Genome-wide association studies in Sjogren's syndrome: What do the genes tell us about disease pathogenesis?","volume":"13","author":"Burbelo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sjogren's syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.001","article-title":"Sjogren's syndrome: a forty-year scientific journey","volume":"51","author":"Moutsopoulos","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0160","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.autrev.2013.03.014","article-title":"Prevalence and clinical significance of rare antinuclear antibody patterns","volume":"12","author":"Vermeersch","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0165","first-page":"S1110","article-title":"Sj\u00f6(TM), an advanced diagnostic panel for detection of Sj\u00f6gren\u2019s Syndrome autoantibodies, arthritis","volume":"66","author":"Jasek","year":"2014","journal-title":"Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0170","first-page":"S319","article-title":"Prediction of cardiac and vascular events in systemic sclerosis: input from endothelin-1 type a receptor antibodies","volume":"66","author":"Avouac","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2013.11.004","article-title":"Diagnostic criteria of systemic sclerosis","volume":"48\u201349","author":"Hudson","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","article-title":"Systemic sclerosis: genetics and epigenetics","volume":"41","author":"Luo","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0185","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.autrev.2014.08.012","article-title":"Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment","volume":"13","author":"Sakkas","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2014.01.027","article-title":"Diagnosis and classification of rheumatoid arthritis","volume":"48\u201349","author":"Kourilovitch","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0195","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.autrev.2012.10.020","article-title":"Different effects of biological drugs in rheumatoid arthritis","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0200","first-page":"S-35-9","article-title":"14-3-3eta: a novel biomarker platform for rheumatoid arthritis","volume":"32","author":"Maksymowych","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0205","first-page":"S837","article-title":"Change in 14-3-3\u2019 expression in early RA patients treated with dmards corresponds with change in DAS28 and good EULAR responses","volume":"66","author":"Van Schaardenburg","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0210","doi-asserted-by":"crossref","first-page":"e001221","DOI":"10.1161\/JAHA.114.001221","article-title":"A novel protein glycan biomarker and future cardiovascular disease events","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2015.03.003_bb0215","first-page":"S837","article-title":"Utility of glyca, a novel inflammatory marker, for assessment of rheumatoid arthritis disease activity","volume":"66","author":"Ormseth","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0220","first-page":"109","article-title":"Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases","volume":"33","author":"Mariani","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0225","doi-asserted-by":"crossref","first-page":"e115800","DOI":"10.1371\/journal.pone.0115800","article-title":"Identification of S100A9 as biomarker of responsiveness to the methotrexate\/etanercept combination in rheumatoid arthritis using a proteomic approach","volume":"9","author":"Obry","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.03.003_bb0230","first-page":"S58","article-title":"Serum calprotectin (S100A8\/9) is an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis","volume":"66","author":"Hurnakova","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0235","first-page":"S704","article-title":"Neutrophil-lymphocyte ratio as a marker of disease activity in psoriatic arthritis","volume":"66","author":"Chandran","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0240","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0245","first-page":"S842","article-title":"Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases: the RORA-as study","volume":"66","author":"Rollefstad","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0250","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2015.03.003_bb0255","first-page":"S818","article-title":"Serum calprotectin and disease relapse in ANCA-associated vasculitis","volume":"66","author":"Draibe","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0260","first-page":"S354","article-title":"Biomarkers of disease activity in vasculitis","volume":"66","author":"Rodriguez-Pla","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.01.013","article-title":"Classification criteria of Sjogren's syndrome","volume":"48\u201349","author":"Goules","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0270","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2012.08.001","article-title":"Diagnostic value of labial minor salivary gland biopsy for Sjogren's syndrome: a systematic review","volume":"12","author":"Guellec","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0275","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.autrev.2013.04.004","article-title":"Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjogren's syndrome","volume":"12","author":"Jimenez","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0280","first-page":"S228","article-title":"Syndrome Collaborative Clinical Alliance (SICCA), The Genetic Basis of Sj\u00f6gren\u2019s Syndrome (SS) Clinical Manifestations from Genome-Wide Association Analysis of Subphenotype Extremes in an International Cohort","volume":"66","author":"Criswell","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0285","first-page":"S226","article-title":"Genetic variant and high levels of CCL11 in serum Are associated with the occurrence of lymphoma and disease activity in primary Sj\u00f6gren\u2019s syndrome patients (pSS)","volume":"66","author":"Nocturne","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0290","first-page":"S1303","article-title":"Identification of whole blood gene expression signature in primary Sj\u00f6gren\u2019s syndrome associated lymphoma","volume":"66","author":"Al-Ali","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0295","first-page":"S227","article-title":"CXCL13 serum levels is associated with lymphoma, high B cells markers and diseases activity in primary Sj\u00f6gren\u2019s syndrome patients","volume":"66","author":"Nocturne","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0300","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.autrev.2013.11.002","article-title":"Towards integrating positron emission tomography for work-up of patients with Sjogren's syndrome and associated lymphomas","volume":"13","author":"Ziakas","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0305","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3899\/jrheum.110754","article-title":"A clinical prediction rule for lymphoma development in primary Sjogren's syndrome","volume":"39","author":"Baldini","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0310","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.autrev.2014.08.022","article-title":"Unmasking the pathogenic role of IL-17 axis in primary Sjogren's syndrome: a new era for therapeutic targeting?","volume":"13","author":"Alunno","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0315","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.autrev.2013.02.003","article-title":"Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies \u2013 novel tool for diagnostics and patient follow-up","volume":"12","author":"Osnes","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0320","first-page":"354","article-title":"The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sjogren's syndrome and its correlation with anxiety and depression","volume":"32","author":"Xie","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0325","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/joim.12115","article-title":"The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjogren's syndrome","volume":"274","author":"Baldini","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2015.03.003_bb0330","unstructured":"C. Baldini, E. Santini, C. Rossi, F. Sernissi, D. Martini, A. Gallo, V. Donati, N. Luciano, F. Ferro, I. Alevizos, A. Solini and S. Bombardieri, Prognostic Value of the Complex P2X7 Receptor-Inflammasome in Patients with Primary Sj\u00f6gren\u2019s Syndrome at Lymphoma Risk., Arthritis Rheumatol 66:S1303."},{"key":"10.1016\/j.autrev.2015.03.003_bb0335","first-page":"S227","article-title":"Whole blood microRNA signature for primary Sj\u00f6gren\u2019s syndrome-related lymphoma","volume":"66","author":"Tarn","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0340","first-page":"S462","article-title":"Type I and II interferon signatures in Sjogren\u2019s syndrome: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphom-agenesis","volume":"66","author":"Nezos","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0345","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.autrev.2013.09.003","article-title":"The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature","volume":"13","author":"De Carolis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0350","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2012.10.018","article-title":"Oral dryness in Sjogren's syndrome patients. Not just a question of water","volume":"12","author":"Castro","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0355","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.autrev.2013.06.012","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computer tomography as an objective tool for assessing disease activity in Sjogren's syndrome","volume":"12","author":"Cohen","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0360","first-page":"S1112","article-title":"How does a younger Age at the onset of Sj\u00f6gren\u2019s syndrome (pSS) influence the clinical presentation and the clinical course of the disease?","volume":"66","author":"Baldini","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0365","first-page":"S1114","article-title":"Renal involvement in primary Sj\u00f6gren\u2019s syndrome: a multicenter French study of 95 biopsy proven cases","volume":"66","author":"Terrier","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0370","first-page":"S1109","article-title":"The Sj\u00f6gren\u2019s syndrome responder index, a data-driven combined endpoint, could detect biologics efficacy","volume":"66","author":"Cornec","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0375","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2012.08.014","article-title":"Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria","volume":"12","author":"Sciascia","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0380","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2012.10.005","article-title":"Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus","volume":"12","author":"Sigges","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0385","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.autrev.2013.07.004","article-title":"Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features","volume":"12","author":"Toledano","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0390","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0395","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.autrev.2014.04.002","article-title":"Neuropsychiatric systemic lupus erythematosus: tools for the diagnosis","volume":"13","author":"Zardi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0400","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2014.11.001","article-title":"Brain abnormalities in newly diagnosed neuropsychiatric lupus: Systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort","volume":"14","author":"Sarbu","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0405","first-page":"S1158","article-title":"Long-term efficacy and safety of pulse cyclophosphamide for neuropsychiatric systemic lupus erythematosus: a Two-centre experience","volume":"66","author":"Fanouriakis","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0410","first-page":"S1159","article-title":"Predictors of incident seizure in systemic lupus erythematosus","volume":"2014","author":"Huang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0415","first-page":"S1158","article-title":"Mood disorders in systemic lupus erythematousus (SLE): results from an international, inception cohort study","volume":"66","author":"Hanly","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0420","article-title":"Prednisone is a risk factor for incident depression in systemic lupus erythematosus","volume":"66","author":"Huang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0425","first-page":"S1163","article-title":"Brain gray and white matter volume losses and their associations with glucocorticoid use in patients with newly diagnosed systemic lupus erythematosus (SLE) \u2013 a prospective MR study","volume":"66","author":"Mak","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0430","first-page":"S1160","article-title":"Cognitive impairment in SLE and non-criterion anti-phospholipid antibodies","volume":"66","author":"Luggen","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0435","first-page":"S1162","article-title":"Cognitive function in systemic lupus erythematosus patients with past history of neuropsychiatric manifestations: a longitudinal study","volume":"66","author":"Gao","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0440","first-page":"S1164","article-title":"Metabolic syndrome features Can influenciate cognitive functions and brain lesions in childhood-onset systemic lupus erythematosus","volume":"66","author":"Sinicato","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0445","first-page":"S1160","article-title":"Predictors of therapeutic outcomes in patients with neuropsychiatric systemic lupus erythematosus","volume":"66","author":"Ichinose","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0450","first-page":"S1161","article-title":"Headache in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume, but not with measures of glial activation, anti-NR2-, or anti-P antibodies","volume":"66","author":"Tjensvoll","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0455","first-page":"S1161","article-title":"Clinical features in patients with anti-triosephosphate isomerase antibody-positive neuropsychiatric systemic lupus erythematosus","volume":"66","author":"Sato","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0460","first-page":"S1165","article-title":"Sense of smell, anti-ribosomal P antibodies and neuropsychiatric manifestations in systemic lupus erythematosus","volume":"66","author":"Peres","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0465","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24491","article-title":"The sense of smell in systemic lupus erythematosus","volume":"60","author":"Shoenfeld","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.003_bb0470","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaut.2008.09.002","article-title":"Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression)","volume":"31","author":"Katzav","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0475","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2007.02.012","article-title":"To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system","volume":"28","author":"Shoenfeld","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0480","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.autrev.2006.07.002","article-title":"To smell the immune system: olfaction, autoimmunity and brain involvement","volume":"6","author":"Strous","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0485","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.autrev.2013.10.013","article-title":"Prednisone in lupus nephritis: how much is enough?","volume":"13","author":"Ruiz-Irastorza","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0490","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.06.002","article-title":"Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus","volume":"54","author":"Sthoeger","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0495","first-page":"S855","article-title":"Neuropsychiatric lupus is substantially unaffected by B-cell deficiency","volume":"66","author":"Wen","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0500","first-page":"S1162","article-title":"Cerebral small vessel disease in systemic lupus erythematosus: histopathological study","volume":"66","author":"Mikdashi","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0505","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.autrev.2011.10.018","article-title":"Is fibromyalgia a discrete entity?","volume":"11","author":"Ablin","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0510","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.autrev.2013.06.006","article-title":"Rheumatic manifestations in inflammatory bowel disease","volume":"13","author":"Atzeni","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0515","first-page":"S153","article-title":"Fibromyalgia: a critical digest of the recent literature","volume":"31","author":"Giacomelli","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0520","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/art.38945","article-title":"Excitatory and inhibitory brain metabolites as targets and predictors of effective motor cortex tDCS therapy in fibromyalgia","volume":"67","author":"Foerster","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0525","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.autrev.2013.10.006","article-title":"Complex regional pain syndrome: a comprehensive and critical review","volume":"13","author":"Borchers","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0530","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.autrev.2012.10.015","article-title":"Complex regional pain syndrome, prototype of a novel kind of autoimmune disease","volume":"12","author":"Goebel","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0535","first-page":"20","article-title":"The evaluation of anxiety and depression status in spouses of sexually active reproductive women with fibromyalgia","volume":"33","author":"Yener","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0540","article-title":"Sleep disturbances of adult women suffering from fibromyalgia: A systematic review of observational studies","author":"Diaz-Piedra","year":"2014","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0545","first-page":"769","article-title":"Understanding fibromyalgia and its resultant disability","volume":"13","author":"Grodman","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2015.03.003_bb0550","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-014-3172-2","article-title":"Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis","author":"Wallace","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2015.03.003_bb0555","first-page":"14","article-title":"The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome","volume":"33","author":"Pernambuco","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0560","first-page":"S121","article-title":"Is fibromyalgia-related oxidative stress implicated in the decline of physical and mental health status?","volume":"31","author":"La Rubia","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0565","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.autrev.2014.08.024","article-title":"Infection-immunity liaison: pathogen-driven autoimmune-mimicry (PDAIM)","volume":"13","author":"Saeki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0570","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.autrev.2014.10.020","article-title":"Infections and antineutrophil cytoplasmic antibodies: Triggering mechanisms","volume":"14","author":"Konstantinov","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0575","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2013.04.003","article-title":"Is there a crossroad between infections, genetics, and Henoch-Schonlein purpura?","volume":"12","author":"Rigante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0580","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2012.12.005","article-title":"Infectome: a platform to trace infectious triggers of autoimmunity","volume":"12","author":"Bogdanos","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0585","first-page":"S826","article-title":"A Combination of Celecoxib and Famciclovir Is Efficacious in the Treatment of Fibromyalgia: Results of a Phase IIa Randomized, Double-Blind, Placebo-Controlled Study","volume":"66","author":"Pridgen","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0590","first-page":"S827","article-title":"The efficacy of pregabalin for treating fibromyalgia patients with moderate or severe baseline widespread pain","volume":"66","author":"Clair","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0595","first-page":"S827","article-title":"Moderate alcohol consumption is associated with lower risk (and severity) of chronic widespread pain: results from a population-based study","volume":"66","author":"Macfarlane","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0600","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/ar4394","article-title":"Can alcohol consumption be an alternative treatment for fibromyalgia?","volume":"15","author":"Chung","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0605","first-page":"S828","article-title":"Patients Who fail biologics are more likely to have concomitant fibromyalgia","volume":"66","author":"Katz","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0610","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.autrev.2012.11.009","article-title":"Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target?","volume":"12","author":"Modena","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0615","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the american college of rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0620","first-page":"S828","article-title":"Examination of patients newly diagnosed with fibromyalgia: Use of guideline-recommended therapies and opioids in clinical practice","volume":"66","author":"Shah","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0625","first-page":"S134","article-title":"Complementary and alternative medicine in fibromyalgia: a practical clinical debate of agreements and contrasts","volume":"31","author":"Cassisi","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0630","first-page":"S395","article-title":"Polysymptomatic distress categories for clinical and research use","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0635","first-page":"S396","article-title":"Development of fibromyalgia and polysymptomatic distress definitions in the national health interview survey","volume":"66","author":"Walitt","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0640","first-page":"S394","article-title":"Symptom increase in fibromyalgia is not consistent with the central sensitization or central hyperresponsiveness hypothesis","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0645","first-page":"S396","article-title":"Small fiber neuropathy in women with fibromyalgia. A clinical pathological-correlation using confocal corneal biomicroscopy","volume":"66","author":"Ram\u00ecrez-Fern\u00e0ndez","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0650","first-page":"S396","article-title":"The fibromyalgia syndrome and widespread pain frequency in active duty U.S. service members with posttraumatic stress disorder","volume":"66","author":"Hildebrand","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0655","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","article-title":"Variation in the human immune system is largely driven by non-heritable influences","volume":"160","author":"Brodin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2015.03.003_bb0660","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaut.2012.05.001","article-title":"Criteria for environmentally associated autoimmune diseases","volume":"39","author":"Miller","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0665","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.3390\/ijms150814269","article-title":"Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease","volume":"15","author":"Parks","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2015.03.003_bb0670","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2012.07.011","article-title":"Heritability versus the role of the environment in autoimmunity","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0675","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaut.2012.05.007","article-title":"Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0680","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","article-title":"Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop","volume":"39","author":"Miller","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0685","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.3390\/ijms151222279","article-title":"Smoking and rheumatoid arthritis","volume":"15","author":"Chang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2015.03.003_bb0690","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0695","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2013.12.002","article-title":"Socioeconomic status. The relationship with health and autoimmune diseases","volume":"13","author":"Calixto","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0700","article-title":"Effects of cigarette smoking on early arthritis: a cross-sectional study-data from the Argentine Consortium for Early Arthritis (CONAART)","author":"Haye Salinas","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2015.03.003_bb0705","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0002-9343(02)01051-3","article-title":"Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study","volume":"112","author":"Criswell","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2015.03.003_bb0710","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","article-title":"A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.003_bb0715","doi-asserted-by":"crossref","first-page":"503 e1-9","DOI":"10.1016\/j.amjmed.2005.09.053","article-title":"Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women","volume":"119","author":"Costenbader","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2015.03.003_bb0720","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies","volume":"69","author":"Sugiyama","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.03.003_bb0725","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar4498","article-title":"Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis","volume":"16","author":"Di Giuseppe","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0730","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar750","article-title":"Smoking-gender interaction and risk for rheumatoid arthritis","volume":"5","author":"Krishnan","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.03.003_bb0735","first-page":"S1262","article-title":"Amount of smoking, duration of smoking cessation, and their interaction with silica exposure in the risk of rheumatoid arthritis: results from the Swedish epidemiological investigation of rheumatoid arthritis study","volume":"66","author":"Jiang","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.003_bb0740","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2013.06.016","article-title":"The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis","volume":"12","author":"Gomez-Puerta","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0745","first-page":"S146","article-title":"Smoking status is associated with inflammatory cytokine profile and disease activity: decreased inflammation and disease improvement with smoking cessation?","volume":"66","author":"Sokolove","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.003_bb0750","first-page":"S186","article-title":"Increasing cartilage turnover in smokers developing rheumatoid arthritis is associated with high disease activity in early disease","volume":"66","author":"Turesson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0755","first-page":"S1104","article-title":"Smoking and response to rituximab in anti-CCP positive and negative rheumatoid arthritis \u2013 results from an international European collaboration","volume":"66","author":"Chatzidionysiou","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0760","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","article-title":"Biologic therapies and systemic bone loss in rheumatoid arthritis","volume":"12","author":"Dimitroulas","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0765","first-page":"S185","article-title":"Smoking functions as a negative regulator of IGF-1 levels and adipokine network in patients with rheumatoid arthritis","volume":"66","author":"Bokarewa","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0770","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.autrev.2013.01.001","article-title":"Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis","volume":"12","author":"Cutolo","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0775","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.autrev.2012.10.001","article-title":"The interaction between CXCL10 and cytokines in chronic inflammatory arthritis","volume":"12","author":"Lee","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0780","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2012.07.011","article-title":"Potential roles for CD8(+) T cells in rheumatoid arthritis","volume":"12","author":"Carvalheiro","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0785","series-title":"A retrospective cohort study using electronic medical records","article-title":"Smoking-related mortality in rheumatoid arthritis","author":"Joseph","year":"2014"},{"key":"10.1016\/j.autrev.2015.03.003_bb0790","first-page":"S1035","article-title":"A pilot randomized controlled trial of a tailored smoking cessation intervention for rheumatoid arthritis patients","volume":"66","author":"Aimer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0795","first-page":"S247","article-title":"Evaluation of clinical parameters and quality of life in smokers with ankylosing spondylitis: results from the Scotland registry for ankylosing spondylitis","volume":"66","author":"Dean","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0800","first-page":"S1130","article-title":"Association of smoking with acute phase reactants and molecules involved in bone formation in patients with ankylosing spondylitis","volume":"66","author":"Sakellariou","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0805","first-page":"S693","article-title":"Joint damage is Not associated with smoking status in patients with psoriatic arthritis","volume":"66","author":"Maldonado-Ficco","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0810","article-title":"Smoking is Not associated with response to TNF blockers in patients with axial spondyloarthritis","volume":"66","author":"Dellyes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0815","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","article-title":"Immunogenicity and autoimmunity during anti-TNF therapy","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0820","first-page":"200","article-title":"Immunogenicity \u2013 implications for rheumatoid arthritis treatment","volume":"71","author":"Solomon","year":"2013","journal-title":"Bull Hosp Jt Dis"},{"key":"10.1016\/j.autrev.2015.03.003_bb0825","doi-asserted-by":"crossref","first-page":"862969","DOI":"10.1155\/2014\/862969","article-title":"Drug retention rates and treatment discontinuation among anti-TNF-alpha agents in psoriatic arthritis and ankylosing spondylitis in clinical practice","volume":"2014","author":"Fabbroni","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2015.03.003_bb0830","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/14740338.2015.993605","article-title":"Safety issues and concerns of new immunomodulators in rheumatology","volume":"14","author":"Selmi","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.autrev.2015.03.003_bb0835","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.04.001","article-title":"The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review","volume":"55","author":"Bao","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0840","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/art.38074","article-title":"Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus","volume":"65","author":"Carter","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.003_bb0845","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0850","first-page":"S858","article-title":"A novel CD27(\u2212) spleen tyrosine kinase (Syk) bright memory B-cell subset is expanded in SLE","volume":"66","author":"Fleischer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0855","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1002\/art.38854","article-title":"Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus","volume":"66","author":"Fleischer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0860","first-page":"S858","article-title":"Circulating CD19 CD38 CD43 B cell subset in SLE patients have more cell cycle related genes than healthy controls","volume":"66","author":"Fujii","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0865","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygeno.2003.08.004","article-title":"Cloning of the rat beta-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters","volume":"83","author":"Li","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.autrev.2015.03.003_bb0870","first-page":"S716","article-title":"Increased CD95 (Fas) expression on naive B cells is associated with a switch to double negative and plasma cells in the peripheral blood, and correlates with disease activity in systemic lupus erythematosus","volume":"66","author":"Ducreux","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0875","doi-asserted-by":"crossref","first-page":"e102231","DOI":"10.1371\/journal.pone.0102231","article-title":"Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study","volume":"9","author":"Kusner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.03.003_bb0880","first-page":"S1178","article-title":"Alterations in B cell subsets and BAFF levels in autoimmune rheumatic diseases treated with B cell depletion therapy: rituximab","volume":"66","author":"Lutalo","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0885","first-page":"S1177","article-title":"Autoregulatory function of IL-10 producing pre-Na\u0131ve B cells is defective in systemic lupus erythematosus","volume":"66","author":"Sim","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0890","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2015.03.003_bb0895","first-page":"S856","article-title":"Targeting CD22 with epratuzumab impacts cytokine production by B cells","volume":"66","author":"Fleischer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0900","first-page":"S443","article-title":"\u20192 adrenoceptor signal is augmented in B cells in the course of arthritis to increase IL-10","volume":"66","author":"Pongratz","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0905","doi-asserted-by":"crossref","first-page":"e85086","DOI":"10.1371\/journal.pone.0085086","article-title":"Adrenergic beta2 receptor activation stimulates anti-inflammatory properties of dendritic cells in vitro","volume":"9","author":"Nijhuis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.03.003_bb0910","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","article-title":"The role of miRNA in inflammation and autoimmunity","volume":"12","author":"Singh","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0915","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaut.2014.07.002","article-title":"DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype","volume":"54","author":"Zhao","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.003_bb0920","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0925","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12016-013-8366-y","article-title":"Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression","volume":"47","author":"Caetano-Lopes","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2015.03.003_bb0930","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1741-7015-12-50","article-title":"Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting","volume":"12","author":"Selmi","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2015.03.003_bb0935","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12026-014-8608-y","article-title":"Discovering the pathogenesis of autoimmune diseases at the 9th International Congress of Autoimmunity, Nice, France, 2014","volume":"60","author":"Perricone","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2015.03.003_bb0940","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.autrev.2014.10.015","article-title":"Autoimmunity cutting edge at the 21st century. Representation of the 9th International Congress of Autoimmunity, Nice, France 2014","volume":"13","author":"Perricone","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.003_bb0945","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12026-014-8605-1","article-title":"Introduction to the special issue on the 9th International Congress on Autoimmunity","volume":"60","author":"Rosenthal","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2015.03.003_bb0950","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2014.05.006","article-title":"Hot topics in autoimmune diseases: perspectives from the 2013 Asian Congress of Autoimmunity","volume":"13","author":"Selmi","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:34:28Z","timestamp":1717828468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":190,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1568997215000658"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.03.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2014 ACR annual meeting: a bird\u2019s eye view of autoimmunity in 2015","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}